102 Cosponsors and counting – use our new Phone Action Alert to call your Rep!
The Lymphedema Treatment Act is off to a strong start this session with 102 members of the House already signed on. All of these cosponsors were the result of constituent
The Lymphedema Treatment Act is off to a strong start this session with 102 members of the House already signed on. All of these cosponsors were the result of constituent
Last week, Primary Lymphedema was one of 10 rare diseases highlighted at the National Organization of Rare Diseases’ annual gala in Washington, DC! Each year NORD honors 10 rare disease
It’s been less than six week since our bill was reintroduced and we already have 62 cosponsors! That’s amazing progress, but we still need many more. If you’ve received a
It is with great pleasure that I present to you this new 13-minute documentary – Lymphedema Treatment Act Public Service Announcement. Please share it far and wide to help us
If you are a Facebook user please post a message on your Representative’s Facebook page today asking him or her to cosponsor the LTA! Click here to find your Rep’s
If you are a Twitter user please tweet your Representative today to ask him or her to cosponsor the LTA! Click here to find your Rep’s Twitter handle and a
We have 31 cosponsors already! Right after our bill was reintroduced Congress went on recess. They’ve just returned, allowing the first batch of cosponsors to be added. Click here to
Last week, on 3/25/15, the Lymphedema Treatment Act was reintroduced. If you haven’t written your Representative since that date please do so today! It only takes a couple of minutes
I’m thrilled to inform you that yesterday, on March 25th, the Lymphedema Treatment Act was reintroduced by Rep Dave Reichert (WA), with co-leads Leonard Lance (NJ), Earl Blumenauer (OR), and
Join our email list to learn about
changes to insurance coverage, advocacy actions,
new educational materials and more.
Subscribers receive approximately
one email per week with information
from both of our organizations.

